Arthur Tzianabos, President & CEO at Homology Medicines, Inc. (FIXX), sold 12,500 shares at $18.75 ($234K) on 2019-09-03, disclosed to the SEC on 2019-09-05.
Open-market sale of $234k FIXX by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| FIXX | SELL | 2024-02-15 | $7K | — | Filing → |
| FIXX | SELL | 2023-01-11 | $15K | — | Filing → |
| FIXX | SELL | 2022-01-12 | $20K | — | Filing → |